Supplements
Supplement: Current and Emerging Treatment Approaches Addess Unmet Needs in Glaucoma Care
Sustained-release implants and micro- or minimally invasive glaucoma surgeries (MIGS) are emerging therapies that address key unmet needs in glaucoma treatment. By broadening the spectrum of interventions, these therapies allow glaucoma specialists to consider more measured approaches earlier in disease progression, with a view to delay as well as safeguard the possibility of further invasive surgeries. Drs. Herbert Reitsamer, Andrew Tatham, and Iqbal Ike K. Ahmed discuss how patient compliance impacts glaucoma progression, the role of sustained-release drug delivery and MIGS in alleviating patient treatment burden, the use of MIGS in combination with cataract surgery, and how these therapies can be incorporated into the treatment paradigm.
Tags: glaucoma
Latest Articles
Rule Number One: Protect the Eyes
Ophthalmologists hold a key role in athlete eye care for all ages and abilities.
Olympic Committee Targets Sports-Related Ophthalmic Issues
Collaboration with sports physicians on risk, treatment, and referral advised.
Global Vision with a Local Flavour
Debates, dry labs, and surgical trainers to highlight 2024 Congress.
Controlling Inflammation after Cataract Surgery
No consensus among leading surgeons regarding whether or how to use a dropless regimen.
Weighing the Cornea Ectasia Risks
Athletes should proceed with care with eye protection solutions.
New Trifocal IOL Delivers Positive Outcomes
Seven diffractive rings offer full range of vision.
Finding a Keratoconus Consensus
Evolving new consensus should help guide diagnosis and management.